Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

Neurocrine Biosciences said on Monday its drug failed to meet the main goal in a late-stage clinical trial in patients with a type of disorder that disrupts the brain's ability to control muscles.

Patients on antipsychotics need to be regularly monitored for signs of tardive dyskinesia, a medication-induced movement disorder diagnosed when the involuntary movements persist for at least a month ...

Danielle Nicole Larson, MD, discusses the mental health burden on patients with tardive dyskinesia, and considerations for clinicians who manage this condition.

A scientific review on autoimmune neurological diseases reveals what occurs in our body when the immune system, by mistake, produces antibodies that target a protein essential for the normal ...

Tardive dyskinesia affects hundreds of thousands of people, yet it often goes unrecognized. The symptoms can be easy to overlook at first — a subtle lip twitch, a slight hand movement, or a bit of ...

In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO ...

Living with movement disorders like tardive dyskinesia (TD) is a unique challenge that affects every sufferer differently. While some people struggle just to keep the involuntary movements at bay, ...

Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia (TD). Playing on the chronic movement disorder’s initialism, the pharma has recruited Pro Football Hall of Famer ...

Yousef Hazimeh is seeking actual, compensatory and punitive damages from Kansas City for all court fees, his job back at KC Water or front pay, according to a petition filed in Jackson County court.